VIRTUAL LEARNING SEMINAR
Understanding Financial Toxicity in the Oncology Population (46:04)
*Watch the Video DEMO (below)
a seminar included in:
- Dan Sherman, MA, LPC - Financial Navigator | Licenced Professional Counselor | Accountant | Educator | Speaker | Consultant | Founder & President of The NaVectis Group
According to the National Cancer Institute, annual direct costs for cancer care are projected to rise – from $104 billion in 2006 to over $158 billion in 2020. Along with the soaring cost of cancer care, treatment costs are increasingly being transferred to the patient and their families. This has created a new issue for oncology patients, called "Financial Toxicity".
The presenter discusses the causes of financial toxicity and how it affects patients from a practical and psychological standpoint. The audience will learn how the effects of financial hardship are directly correlated to treatment adherence, quality of life, and impact of medical care.
The statistics of financial toxicity continue to rise, and the presenter discusses the role that the cancer care team should play in assessing their current financial advocacy model and incorporating financial navigation as a part of standardized care.
The audience will gain knowledge of the benefits that a financial navigation program has in reducing patients' financial burden, increasing profit margins, alleviating patient distress, improving access to care, and boosting patient satisfaction scores.
- Define financial toxicity in the oncology setting
- Discuss the many causes of financial toxicity
- Consider the psychological ramifications of financial toxicity